Comments
Loading...

ARS Pharmaceuticals Informe de interés a corto plazo

SPRYNASDAQ
Logotipo presentado por Benzinga Data
$6.73
-0.36-5.08%
al cierre: Nov 20, 4:00 PM EST
$6.78
0.04970.74%
After hour: 7:21 PM EST

Informe de interés en corto

El interés corto en ARS Pharmaceuticals Inc (NASDAQ:SPRY) ha aumentado durante el último período de informe, aumentando en aumento desde 18.96M hasta 19.76M. Esto representa el 32.56% de las acciones disponibles públicamente de la empresa.

Basado en el volumen promedio reciente de 1.66M acciones negociadas por día, tomaría 11.89 día(s) para que los poseedores de este interés corto cierren sus posiciones sin impulsar bruscamente el precio de las acciones.

Interés en corto
19.76M
Interés en corto %
32.6%
Días para cubrir
11.89
Get Alert
SPRY
ARS Pharmaceuticals, Inc. Comm
10/31/2025
11/11/2025
32.56%
60,676,488
19,756,847
1,662,251
11.89
SPRY
ARS Pharmaceuticals, Inc. Comm
10/15/2025
10/24/2025
31.27%
60,654,214
18,964,276
2,607,655
7.27
SPRY
ARS Pharmaceuticals, Inc. Comm
09/30/2025
10/09/2025
35.76%
60,654,214
21,690,186
2,583,916
8.39
SPRY
ARS Pharmaceuticals, Inc. Comm
09/15/2025
09/24/2025
35.58%
60,654,214
21,583,515
3,535,411
6.1
SPRY
ARS Pharmaceuticals, Inc. Comm
08/29/2025
09/10/2025
34.69%
60,654,214
21,041,326
2,600,064
8.09
SPRY
ARS Pharmaceuticals, Inc. Comm
08/15/2025
08/26/2025
29.29%
60,654,214
17,765,896
1,861,836
9.54
SPRY
ARS Pharmaceuticals, Inc. Comm
07/31/2025
08/11/2025
25.55%
60,041,438
15,339,705
1,291,962
11.87
SPRY
ARS Pharmaceuticals, Inc. Comm
07/15/2025
07/24/2025
24.76%
60,041,438
14,864,141
1,251,652
11.88
SPRY
ARS Pharmaceuticals, Inc. Comm
06/30/2025
07/10/2025
26.30%
60,041,438
15,789,752
1,991,557
7.93
SPRY
ARS Pharmaceuticals, Inc. Comm
06/13/2025
06/25/2025
27.61%
60,041,438
16,577,058
932,688
17.77
SPRY
ARS Pharmaceuticals, Inc. Comm
05/30/2025
06/10/2025
28.54%
60,041,438
17,135,687
1,505,653
11.38
SPRY
ARS Pharmaceuticals, Inc. Comm
05/15/2025
05/27/2025
30.36%
60,041,438
18,230,628
1,462,795
12.46
SPRY
ARS Pharmaceuticals, Inc. Comm
04/30/2025
05/09/2025
31.79%
52,626,556
16,727,585
1,246,232
13.42
SPRY
ARS Pharmaceuticals, Inc. Comm
04/15/2025
04/25/2025
31.28%
52,626,556
16,461,184
2,019,839
8.15
SPRY
ARS Pharmaceuticals, Inc. Comm
03/31/2025
04/09/2025
32.59%
52,626,556
17,150,346
2,621,785
6.54
SPRY
ARS Pharmaceuticals, Inc. Comm
03/14/2025
03/25/2025
36.92%
52,626,556
19,429,266
1,318,622
14.73
SPRY
ARS Pharmaceuticals, Inc. Comm
02/28/2025
03/11/2025
36.76%
51,692,227
19,003,671
1,245,803
15.25
SPRY
ARS Pharmaceuticals, Inc. Comm
02/14/2025
02/26/2025
31.89%
51,692,227
16,483,868
1,157,920
14.24
SPRY
ARS Pharmaceuticals, Inc. Comm
01/31/2025
02/11/2025
28.38%
51,692,227
14,670,470
1,405,708
10.44
SPRY
ARS Pharmaceuticals, Inc. Comm
01/15/2025
01/27/2025
28.65%
51,692,227
14,810,932
1,379,774
10.73
SPRY
ARS Pharmaceuticals, Inc. Comm
12/31/2024
01/10/2025
26.46%
51,692,227
13,675,218
1,449,691
9.43
SPRY
ARS Pharmaceuticals, Inc. Comm
12/13/2024
12/24/2024
24.49%
51,692,227
12,656,935
1,049,459
12.06
SPRY
ARS Pharmaceuticals, Inc. Comm
11/29/2024
12/10/2024
26.37%
51,692,227
13,629,789
891,556
15.29
SPRY
ARS Pharmaceuticals, Inc. Comm
11/15/2024
11/26/2024
26.80%
51,692,227
13,852,113
1,610,826
8.6
SPRY
ARS Pharmaceuticals, Inc. Comm
10/31/2024
11/11/2024
24.49%
51,448,361
12,597,445
928,508
13.57
SPRY
ARS Pharmaceuticals, Inc. Comm
10/15/2024
10/24/2024
23.16%
51,448,361
11,915,667
786,205
15.16
SPRY
ARS Pharmaceuticals, Inc. Comm
09/30/2024
10/09/2024
21.57%
51,448,361
11,097,485
1,070,102
10.37
SPRY
ARS Pharmaceuticals, Inc. Comm
09/13/2024
09/24/2024
22.62%
51,448,361
11,637,226
915,086
12.72
SPRY
ARS Pharmaceuticals, Inc. Comm
08/30/2024
09/11/2024
21.30%
51,448,361
10,960,219
1,551,924
7.06
SPRY
ARS Pharmaceuticals, Inc. Comm
07/31/2024
08/09/2024
19.29%
51,448,361
9,925,990
587,738
16.89
SPRY
ARS Pharmaceuticals, Inc. Comm
07/15/2024
07/24/2024
17.00%
51,402,008
8,738,917
723,751
12.07
SPRY
ARS Pharmaceuticals, Inc. Comm
06/28/2024
07/10/2024
13.39%
51,402,008
6,881,590
1,028,228
6.69
SPRY
ARS Pharmaceuticals, Inc. Comm
06/14/2024
06/26/2024
13.32%
51,402,008
6,848,914
400,019
17.12
SPRY
ARS Pharmaceuticals, Inc. Comm
05/31/2024
06/11/2024
13.27%
51,402,008
6,818,939
353,757
19.28
SPRY
ARS Pharmaceuticals, Inc. Comm
05/15/2024
05/24/2024
13.37%
51,402,008
6,869,975
439,580
15.63
SPRY
ARS Pharmaceuticals, Inc. Comm
04/30/2024
05/09/2024
12.41%
51,402,008
6,380,357
478,251
13.34
SPRY
ARS Pharmaceuticals, Inc. Comm
04/15/2024
04/24/2024
11.84%
51,401,146
6,087,282
550,728
11.05
SPRY
ARS Pharmaceuticals, Inc. Comm
03/28/2024
04/09/2024
9.15%
60,093,120
5,499,624
1,199,083
4.59
SPRY
ARS Pharmaceuticals, Inc. Comm
03/15/2024
03/26/2024
7.08%
60,093,120
4,254,773
737,973
5.77
SPRY
ARS Pharmaceuticals, Inc. Comm
02/29/2024
03/11/2024
7.68%
60,006,529
4,609,565
1,017,649
4.53
SPRY
ARS Pharmaceuticals, Inc. Comm
01/31/2024
02/09/2024
8.16%
59,588,818
4,861,658
314,374
15.46
SPRY
ARS Pharmaceuticals, Inc. Comm
01/12/2024
01/24/2024
11.65%
59,588,818
6,942,449
279,959
24.8
SPRY
ARS Pharmaceuticals, Inc. Comm
12/29/2023
01/10/2024
11.69%
59,588,818
6,968,061
332,577
20.95
SPRY
ARS Pharmaceuticals, Inc. Comm
12/15/2023
12/27/2023
11.21%
59,588,818
6,677,214
458,662
14.56
SPRY
ARS Pharmaceuticals, Inc. Comm
11/30/2023
12/11/2023
10.12%
59,588,818
6,029,962
493,509
12.22
SPRY
ARS Pharmaceuticals, Inc. Comm
11/15/2023
11/27/2023
9.96%
59,588,818
5,936,549
1,005,979
5.9